๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects

โœ Scribed by J. Dingemanse; I. Berlin; C. Payan; H. M. Thiede; A. J. Puech


Publisher
Springer
Year
1992
Tongue
English
Weight
209 KB
Volume
106
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The effects of acute and repeated doses
โœ J. S. Kerr; D. B. Fairweather; I. Hindmarch ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 578 KB

The effects of moclobemide, a new selective and reversible MAO-A inhibitor, on cognitive function and psychomotor performance were measured in 12 healthy elderly male volunteers (with a mean age of 72.5 years). Subjects received moclobemide 200 mg, amitriptyline (positive internal control) 25 mg or

The effects of somanin vitro on catechol
โœ Hsu, Chia-Hsuh ;Hu, Chao-Yu ;Robinson, Casey P. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 335 KB ๐Ÿ‘ 1 views

## Abstract Soman (pinacolyl methylphosphonofluoridate) not only increases acetylcholine levels by inhibiting cholinesterases, it also alters the levels of some other neurotransmitters including norepinephrine, dopamine, and serotonin. Soman also causes an alteration in the activities of the enzyme